FDA Clears Omadacycline (Nuzyra) for ABSSSI and CABP FDA Clears Omadacycline (Nuzyra) for ABSSSI and CABP

Omadacycline is a modernized tetracycline with broad-spectrum activity that is designed to overcome tetracycline resistance.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Alert Source Type: news